Related Experiment Video
Updated: Jul 16, 2025

18:30
RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells
Published on: February 13, 2013
22.0K
Whole Blood Transcriptomics Identifies Subclasses of Pediatric Septic Shock
Jamie O Yang1, Matt S Zinter2, Matteo Pellegrini1
1University of California, Los Angeles.
Research Square
|September 11, 2023
Summary
Researchers identified two distinct pediatric septic shock subclasses using whole blood RNA sequencing. Subclass 1 showed worse outcomes, with altered immune pathways and lower T-cell diversity, highlighting potential for precision medicine in sepsis treatment.
Area of Science:
- Pediatric critical care medicine
- Immunology
- Genomics
Background:
- Sepsis heterogeneity impedes effective therapy development.
- Precision medicine requires identifying biologically homogenous patient subgroups.
- Transcriptomic analysis offers a pathway to identify novel therapeutic targets.
Approach:
- Genome-wide expression profiling via RNA-sequencing was performed on whole blood samples from pediatric septic shock patients and controls.
- Hierarchical clustering of gene expression identified distinct septic shock subclasses.
- Clinical characteristics, inflammatory markers, cell compositions, and immune repertoires were compared between subclasses.
Key Points:
- Two distinct pediatric septic shock subclasses were identified based on gene expression patterns.
- Subclass 1 exhibited upregulated innate immunity and downregulated adaptive immunity pathways.
- Subclass 1 patients experienced worse clinical outcomes, elevated inflammatory cytokines, and endothelial injury biomarkers, despite similar initial illness severity.
Conclusions:
- Genome-wide expression profiling revealed two subclasses of pediatric septic shock with significant biological and clinical differences.
- These findings support a precision medicine approach for pediatric septic shock.
- Subclassifications may guide targeted therapeutic strategies for improved patient outcomes.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
200
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
200
Blood Pressure Imbalances and Circulatory Shock
808
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
808

